To achieve our vision of a world without ALS, we support nearly every stage of research, from identifying ALS-linked genes and biomarkers to discovering and developing new treatments to optimizing current treatment approaches and quality of life. We also encourage young scientists to pursue careers in ALS and build research and clinical trial infrastructure to cultivate a robust pipeline of innovative ideas that can lead to better ALS treatments and ultimately a cure.
Image
Research Grants
Lawrence and Isabel Barnett Drug Development Program
This grant program supports preclinical drug discovery and development of new or repurposed treatments for ALS.
These grants support efforts to increase participation and diversity in ALS clinical trials as well as efforts to improve the speed and efficiency of these trials.
These awards provide 1 year of support so researchers can gather the data needed to secure follow-on funding and partnerships to advance potentially impactful ALS research.
This program supports the development of early-career scientists by funding junior postdoctoral fellows doing research of high scientific merit and relevance to ALS.
These awards, established in partnership with the American Academy of Neurology and American Brain Foundation, give young investigators the experience they need to establish their own ALS research laboratories and continue moving their innovative ideas toward the clinic.
To help make ALS a livable disease until we can cure it, we annually review and refine our research portfolio with input from our Research Committee. Click below to explore current and past requests for applications.